HomeCoronary diseaseAcute coronary syndromes

Acute coronary syndromes

Ver Categoría

Acute coronary syndromes

ESC 2025 | DUAL-ACS: Duration of Dual Antiplatelet Therapy in Acute Coronary Syndromes

The DUAL-ACS trial, a randomized multicenter study, was designed to evaluate whether a strategy of P2Y12 inhibitor...
Dr. Juan Manuel Pérez -
Ver más
Acute coronary syndromes

ESC 2025 | OPTION-STEMI: Timing of Complete Revascularization During the Initial Hospitalization in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease

In patients with ST-segment elevation myocardial infarction (STEMI) and multivessel coronary artery disease (MVD), the optimal timing...
Dr. Juan Manuel Pérez -
Ver más
Acute coronary syndromes

Abbreviated Dual Antiplatelet Therapy with Prasugrel: 4D-ACS

The optimal duration of dual antiplatelet therapy (DAPT) in acute coronary syndrome (ACS) remains subject to controversy....
Dr. Omar Tupayachi -
Ver más
Acute coronary syndromes

Use of Plaque Modifying Devices in Calcified Left Main Lesions

Treating severely calcified left main coronary artery (LMCA) lesions is one of the greatest challenges in interventional...
Dr. Omar Tupayachi -
Ver más
Acute coronary syndromes

Early Discharge After STEMI: Clinical Benefit and Cost-Effectiveness?

Improvements in reperfusion strategies for ST-segment elevation myocardial infarction (STEMI) have transformed the prognosis for this condition....
Dr. Omar Tupayachi -
Ver más
Acute coronary syndromes

PROSPECT II Substudy: Relationship Between Different Levels of hs-CRP and Vulnerable Plaque Characteristics in Patients with NSTEMI

Inflammation plays a key role in the onset and progression of atherosclerosis and has been linked to...
Dr. Andrés Rodríguez -
Ver más
Acute coronary syndromes

Aspirin vs. Clopidogrel Monotherapy After 1 Month of ACS: Subgroup Analysis Based on Bleeding Risk and MI Type

Current guidelines still recommend dual antiplatelet therapy (DAPT) for 12 months following percutaneous coronary intervention (PCI) as...
Dr. Andrés Rodríguez -
Ver más
Acute coronary syndromes

EuroPCR 2025 | DANAMI-3-DEFER: 10-Year Results of Deferred vs. Conventional Stenting in STEMI Patients

Primary percutaneous coronary intervention (PCI) with stent implantation is the recommended treatment for ST-segment elevation myocardial infarction...
Dr. Andrés Rodríguez -
Ver más